GlassScriptPhysician profile
Donald Spadone
NPI 1114935434
$9,303.82
in general payments reported to CMS, 2019-2025
36 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,813 · 2020: $426 · 2021: $821 · 2022: $594 · 2023: $2,145 · 2024: $1,475 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,558 · Travel and Lodging: $91.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,558.40 |
| Travel and Lodging | $91.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $2,358.01 | 2019-2025 | Asahi Ptca Guide Wire, Peripheral Vascular, Asahi Peripheral Vascular Wires |
| Medtronic USA, INC. | $1,139.74 | 2019 | |
| Shockwave Medical, INC | $777.00 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $636.07 | 2021-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Janssen Pharmaceuticals, INC | $601.18 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $496.98 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Penumbra, INC. | $441.18 | 2022-2024 | Indigo System, Penumbra System |
| Abbott Laboratories | $334.63 | 2021-2024 | Esprit, Xience Sierra, Mitraclip |
| Endologix LLC | $295.48 | 2019-2025 | Alto Abdominal Stent Graft System |
| Boston Scientific Corporation | $225.66 | 2020-2025 | Ekosonic, Avvigo Guidance System, Enroute Transcarotid Stent |
| Cvrx, INC. | $200.92 | 2022-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $195.34 | 2021-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $187.09 | 2023-2024 | Lifevest |
| Abiomed | $162.89 | 2019-2022 | |
| Bolton Medical INC | $154.50 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $144.76 | 2025 | Manta |
| Celonova Biosciences, INC. | $137.21 | 2020 | |
| Pfizer INC. | $104.98 | 2019 | |
| Philips North America LLC | $103.72 | 2023 | |
| Medtronic, INC. | $86.94 | 2021-2022 | |
| Medtronic Vascular, INC. | $86.79 | 2019-2020 | |
| Stryker Corporation | $84.25 | 2025 | Triever20, Artix Mt |
| Silk Road Medical, INC. | $51.08 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Astrazeneca Pharmaceuticals LP | $41.30 | 2021-2024 | Farxiga |
| Atricure, INC. | $40.57 | 2019 | |
| Surmodics, INC. | $31.32 | 2023 | Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System |
| Inari Medical, INC. | $29.71 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.45 | 2025 | Jardiance |
| Novo Nordisk INC | $25.14 | 2025 | Wegovy |
| Cashflow Solutions, LLC | $16.91 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Amarin Pharma, INC. | $16.48 | 2021 | |
| Astellas Pharma US INC | $16.02 | 2019 | |
| Tactile Systems Technology INC | $14.90 | 2023 | Flexitouch Plus, Entre Plus |
| Novartis Pharmaceuticals Corporation | $14.16 | 2023 | |
| Chiesi USA, INC. | $12.95 | 2023 | Kengreal, Cleviprex |
| Ge Healthcare | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Spadone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.